Cargando…
Different expression levels of interleukin-35 in asthma phenotypes
BACKGROUND: Interleukin (IL)-35 is a newly discovered inhibitory cytokine which is produced by regulatory B and T lymphocytes and belongs to the IL-12 family. It plays a suppressive role in human inflammatory diseases; however, its role in asthma phenotypes is unclear. Our study focuses on the sputu...
Autores principales: | Li, Wei, Gao, Ruihan, Xin, Tong, Gao, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160921/ https://www.ncbi.nlm.nih.gov/pubmed/32295589 http://dx.doi.org/10.1186/s12931-020-01356-6 |
Ejemplares similares
-
Interleukin-32: its role in asthma and potential as a therapeutic agent
por: Xin, Tong, et al.
Publicado: (2018) -
Elevated levels of interleukin‐35 and interleukin‐37 in adult patients with obstructive sleep apnea
por: Chen, Bi, et al.
Publicado: (2021) -
Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022) -
Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent
por: Gao, Peng, et al.
Publicado: (2017) -
Interleukin-35 expression is associated with colon cancer progression
por: Zhang, Jian, et al.
Publicado: (2017)